Background. Among persons with HIV infection, low bone mineral density is common and has raised concerns about increased risk of fracture.
Low bone mineral density (BMD) is common among persons with human immunodeficiency virus (HIV) infection [1] [2] [3] [4] . A recent meta-analysis estimated that 67% of HIV-infected persons exhibited reduced BMD, and 15% had osteoporosis [5] . The increased prevalence of low BMD among HIV-infected patients has raised concerns that as cohorts of HIV-infected patients age, bone fracture rates will increase [6] . Although multiple analyses have reported decreased BMD in HIV-infected persons, there are few data regarding incidence rates of fractures [7] [8] [9] . One US report found that fracture prevalence was increased significantly in both HIV-infected men and HIV-infected women, compared with persons whose HIV status was negative or unknown [7] . A study of antiretroviral (ART)-treated HIV-infected persons in France from 1997 through 2007 found an increasing incidence of fractures, but this study did not include a general population comparison group [8] .
In this report, we compared rates of bone fracture among a large and demographically diverse cohort of ambulatory HIV-infected adults with rates of bone fracture among adult outpatients in the general US population and explored risk factors for incident fractures among HIVinfected adults.
METHODS
The HIV Outpatient Study (HOPS) is an open, prospective observational cohort study of HIV-infected adults followed at 10 specialty clinics in 8 US cities and has been described elsewhere [10, 11] . We analyzed data from HOPS patients with at least 2 clinical encounters during the period from 1 January 2000 through 31 December 2008 using HOPS data updated as of 13 March 2009.
Identification of Fractures Among HOPS Patients
Since 2000, HOPS electronic databases have specifically captured data on fracture events and their anatomic site. Fractures that were treated at facilities outside of a HOPS site were recorded when a discharge summary was available or from patient self-report. Subjects were not systematically queried as to whether they had experienced a fracture between outpatient encounters. For our analyses, we included only the first bone fracture (at any anatomic site) during the observation period. We defined as fragility fractures those occurring at the following sites: wrist, vertebra, and femoral neck of the hip.
Identification of Bone Fractures Among Adults in the US General Population
We compared fracture rates among HOPS patients with rates estimated for the US general population using data from the Centers for Disease Control and Prevention-funded National Hospital Ambulatory Medical Care Survey of outpatient departments (NHAMCS-OPDs), which were available through 2006 at the time of this analysis [12] . Specific methodology for data acquisition for NHAMCS has been described elsewhere [13] [14] [15] . Any fractures were identified by first-listed or primary International Classification of Diseases, Ninth Edition, discharge codes 800-829, as recorded in charts or in discharge records.
Classification of Risk Factors in the HOPS
Risk factors for fracture in the contemporary HAART era (2002) (2003) (2004) (2005) (2006) (2007) (2008) were defined according to status as of 1 January 2002 or at first HOPS visit thereafter (defined as baseline). Potential risk factors included basic demographic and clinical factors (eg, age, sex, HIV transmission risk group, AIDS status, body mass index [BMI, calculated as the weight in kilograms divided by the square of height in meters]); known risk factors for low BMD (eg, current tobacco smoking, alcohol use, substance abuse, certain comorbid conditions, use of certain prescribed medications); baseline CD41 cell count and plasma HIV RNA level; and exposure to highly active antiretroviral therapy (HAART). We defined patients as hepatitis C virus (HCV) infected if their medical record contained a diagnosis of HCV infection, evidence HCV seropositivity, or detectable plasma HCV RNA. a Among antiretroviral therapy-experienced persons, the median viral load was 2.3 log 10 copies/mL, and 53.8% had a viral load ,400 copies/mL; Among antiretroviral therapy-naive persons, the median viral load was 4.6 copies/mL.
Statistical Analysis
We first calculated overall and age-specific annualized rates (per 10,000 persons) of bone fracture among HOPS patients and among US adults using the NHAMCS-OPD [12, 13] . For a given year, only HOPS patients with >1 clinical encounter during that year were included. We indirectly standardized fracture rates among HOPS patients using fracture rates from NHAMCS-OPD and applying the age and sex distribution of the HOPS patients as weights [16] . We assessed trends in the annual fracture rate using linear regression, and we assessed the differences in the proportions of fractures focusing on subjects 25-54 years of age using the v 2 test.
We used Cox proportional hazards modeling to examine risk factors for fracture. Observations were censored at date of fracture, patient's last contact with the HOPS, death, or 31 December 2008, whichever occurred first. Factors associated with fracture at the P , .20 level were evaluated in multivariable models that adjusted for sex and age. We used SAS, version 9.2, for analyses of HOPS data and SUDAAN for analyses of NHAMCS data. Associations with a P value <.05 were considered statistically significant.
RESULTS

Trends in Fracture Incidence
Of 5826 HOPS patients with data analyzed (median age, 40 years), 79.0% were male, 51.8% were non-Hispanic white, and 72.7% were exposed to ART (Table 1) Crude fracture rates, as well as age-and sex-adjusted fracture rates, among HOPS patients and in the general US population surveyed by the NHAMCS-OPD are shown in Table 2 . Differences in standardized rates were statistically significant (ie, there was no overlap between 95% CIs) in most years overall and for men, although not for women (Table 2) . Among all HOPS patients and among those ages 25-54 years, who constituted 87% of all the HOPS patients included in this analysis, standardized rates of fracture increased significantly during the period 2000-2008 (P 5 .01, Figure 1 ) and were consistently higher than rates in NHAMCS-OPD during 2000-2006 (95% CIs not shown).
HOPS men aged 25-54 years experienced proportionally more fractures at the wrist and vertebra (P , .01, Table 3 ). HOPS women aged 25-54 years experienced proportionally more fractures at vertebra and femoral neck sites (P , .01 and P 5 .04, respectively). Both HOPS men and women experienced relatively fewer fractures at nonfragility sites, compared with NHAMCS-OPD patients (Table 3) .
Risk Factors Associated With Fractures in HOPS Patients
In univariate Cox proportional hazards analyses, age .47 years, CD41 cell count nadir ,200 cells/mm 3 , baseline AIDS diagnosis, current tobacco use, HCV infection, diabetes, substance abuse, and peripheral neuropathy were associated (P , .05) with increased fracture risk in the contemporary HAART era ( Table 4 ). There were no observed associations between risk of fracture and sex, race/ethnicity, age, BMI, ART exposure, and use of selective serotonin reuptake inhibitors (SSRIs), proton pump inhibitors, or thiazolidinediones. In multivariable analyses, factors associated with increased fracture risk included age .47 years, nadir CD41 cell count ,200 cells/mm 3 , HCV infection, diabetes, and substance abuse ( 
DISCUSSION
In this large and diverse cohort of HIV-infected US adults, incident first fracture rates increased slightly during the period Age-adjusted fracture rates among HIV-infected men and women ages 25-54 years in the HOPS were consistently higher than those in adults in the US general population captured by the NHAMCS-OPD during the study period. Moreover, the relative proportion of fractures at fragility sites (spine, hip, and wrist) was higher among HOPS patients than among participants surveyed in the NHAMCS-OPD. Among HOPS patients, increasing age, HCV co-infection, and BMI ,18.5 were independently associated with fragility fractures. Our finding that incident fracture rates among HIV-infected HOPS patients were greater than rates among predominantly HIV-uninfected counterparts in the general population confirms similar findings from prior reports [7] . The slight annual increase in fracture rates among the HOPS patients might reflect a true increase as HIV-infected patients experience improved survival or an improved capture of fracture data within the HOPS because of increasing awareness of bone health issues, or both.
We confirmed that several established risk factors for fracture (ie, older age, substance abuse, HCV co-infection and diabetes) were associated with incident fractures among HOPS patients. The Veterans Aging Cohort Study documented that incident fragility fractures were independently associated with HIV infection, as well as with cachexia, white race/ethnicity, alcohol abuse, and increasing age [17] . The Women's Interagency HIV Study (WIHS) found that fractures were associated with white race/ethnicity, increasing age, a history of AIDS-defining illness, and a history of prior fracture [18] but found no association with HIV infection in this generally young cohort of mostly premenopausal women [18] . Although previous studies have linked advanced HIV disease and its markers to low BMD, we believe that our analysis is the first to highlight a possible association of low nadir CD41 cell count with incident fracture rates. The causal mechanism by which low nadir CD41 cell count is associated with low BMD and fracture risk is unclear and warrants further investigation.
The optimal clinical management of bone health in HIVinfected individuals is not well defined and remains controversial. Screening HIV-infected adults for fracture risk has been recommended for individuals aged >40 years by the European AIDS Clinical Society and >50 years by McComsey and colleagues [19, 20] . Our findings suggest that younger HIV-infected adults are also at significant risk for fragility fractures and should be considered for similar screening interventions.
This analysis has several important limitations. First, bone fractures were ascertained from diagnoses of clinical events charted by HIV care providers and were not confirmed by review of radiographic findings or central adjudication. Second, subjects were not routinely queried about bone fractures that occurred outside of the HOPS clinic, which could have led to under-reporting of events that biased our analysis towards underestimation of fracture incidence. Third, for a majority of HOPS patients, we were not able to systematically determine the clinical venue where they initially presented for treatment of their fracture and thus could not restrict comparisons of HOPS data with national datasets by place of initial treatment (ie, hospital, outpatient clinic, or emergency department). Nevertheless, we believe that, despite methodological differences in fracture ascertainment, NHAMCS-OPD was our best available source of comparative data on fracture rates in the general population. Like the HOPS, the NHAMCS-OPD captures fractures among adults who initially present to outpatient departments for treatment of a fracture, who present to outpatient departments for follow-up treatment of a fracture, or who report a fracture to their health care provider, at which point this event is captured in their medical record and abstracted. Fourth, in both the HOPS and NHAMCS-OPD, we were unable to assess the completeness with which fracture events were captured; however, we have no a priori reason to believe that completeness would differ meaningfully between these datasets in a direction that would have biased against the null hypothesis. Fifth, although our analysis of HOPS data included .5800 patients, fractures are rare events, and rates in the HOPS are thus subject to considerable variability, which limited our ability to stratify by age, sex, and race/ethnicity. Sixth, we had no data on BMD for HOPS patients and were thus unable to assess its contribution to the risk of fracture. Finally, we did not have adequate data on use of tobacco, alcohol, or other substances of abuse among HOPS patients to explore a dose-response association of exposure to these agents with the risk of fracture. In summary, our study suggests that HIV-infected adults, particularly adults age 25-54 years of age, are at an increased risk of bone fracture, compared with the general population. In light of this finding and the established relationship between low BMD and increased fracture risk in the general adult population, we recommend that screening for and correcting reversible causes of low BMD and fall risk be incorporated into routine clinical care of HIV-infected patients, as has been recently argued [20] .
